Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$359.49 - $486.4 $13.3 Million - $18 Million
-37,100 Reduced 97.12%
1,100 $417,000
Q1 2023

May 12, 2023

SELL
$418.69 - $503.0 $26.8 Million - $32.2 Million
-63,943 Reduced 62.6%
38,200 $18.3 Million
Q4 2022

Feb 13, 2023

BUY
$351.71 - $456.01 $13.9 Million - $18 Million
39,443 Added 62.91%
102,143 $43 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $37.9 Million - $51.7 Million
-91,800 Reduced 59.42%
62,700 $26.2 Million
Q2 2022

Aug 12, 2022

SELL
$463.67 - $597.16 $15.4 Million - $19.9 Million
-33,300 Reduced 17.73%
154,500 $76.5 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $69 Million - $96.8 Million
131,600 Added 234.16%
187,800 $106 Million
Q4 2021

Feb 11, 2022

BUY
$708.84 - $794.68 $11.8 Million - $13.2 Million
16,600 Added 41.92%
56,200 $42.5 Million
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $4.8 Million - $6.03 Million
-7,300 Reduced 15.57%
39,600 $29.5 Million
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $2.54 Million - $2.86 Million
-4,400 Reduced 8.58%
46,900 $30.2 Million
Q1 2021

May 13, 2021

BUY
$547.01 - $662.35 $28.1 Million - $34 Million
51,300 New
51,300 $29.3 Million
Q4 2020

Feb 10, 2021

SELL
$510.68 - $643.45 $24.2 Million - $30.5 Million
-47,400 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $7.09 Million - $8.36 Million
15,600 Added 49.06%
47,400 $24.4 Million
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $10 Million - $14.7 Million
-29,900 Reduced 48.46%
31,800 $14.4 Million
Q1 2020

May 14, 2020

SELL
$320.01 - $409.07 $5.34 Million - $6.83 Million
-16,700 Reduced 21.3%
61,700 $21.6 Million
Q4 2019

Feb 13, 2020

BUY
$319.73 - $374.2 $8.03 Million - $9.39 Million
25,100 Added 47.09%
78,400 $29 Million
Q3 2019

Nov 13, 2019

SELL
$304.55 - $345.24 $23.9 Million - $27.1 Million
-78,600 Reduced 59.59%
53,300 $17.7 Million
Q2 2019

Aug 12, 2019

SELL
$286.93 - $312.59 $7.14 Million - $7.78 Million
-24,900 Reduced 15.88%
131,900 $41.2 Million
Q1 2019

May 14, 2019

BUY
$224.3 - $317.41 $20.7 Million - $29.4 Million
92,500 Added 143.86%
156,800 $47.9 Million
Q4 2018

Feb 13, 2019

BUY
$220.1 - $309.0 $14.2 Million - $19.9 Million
64,300 New
64,300 $14.9 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.38B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.